Literature DB >> 27784192

The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders.

Jianjun Ou1, Ming Li2, Xiao Xiao2.   

Abstract

OBJECTIVES: Genome-wide association studies (GWAS) followed by independent replications suggest that ZNF804A is a risk gene for schizophrenia (SCZ), considering the substantial genetic overlap between SCZ and major mood disorders (e.g., bipolar disorder (BPD) and major depressive disorder (MDD)).
METHODS: We collected the data of two ZNF804A single-nucleotide polymorphisms (SNPs rs1344706 and rs7597593) from European and Asian populations to perform systematic meta-analyses with major mood disorders in a total of 65,240 subjects.
RESULTS: Meta-analysis showed that rs1344706 and rs7597593 were both associated with major mood disorders as well as diagnosis of either BPD or MDD, although neither of the analyses achieved a genome-wide level of statistical significance.
CONCLUSIONS: Our data provide evidence for the genetic involvement of ZNF804A SNPs in the susceptibility of major mood disorders, but further replication analyses in larger samples are necessary.

Entities:  

Keywords:  GWAS; ZNF804A; bipolar disorder; major depressive disorder; schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27784192     DOI: 10.1080/15622975.2016.1252466

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  6 in total

1.  Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders.

Authors:  Xiao Xiao; Lu Wang; Chuang Wang; Ti-Fei Yuan; Dongsheng Zhou; Fanfan Zheng; Lingyi Li; Maria Grigoroiu-Serbanescu; Masashi Ikeda; Nakao Iwata; Atsushi Takahashi; Yoichiro Kamatani; Michiaki Kubo; Martin Preisig; Zoltán Kutalik; Enrique Castelao; Giorgio Pistis; Najaf Amin; Cornelia M van Duijn; Andreas J Forstner; Jana Strohmaier; Julian Hecker; Thomas G Schulze; Bertram Müller-Myhsok; Andreas Reif; Philip B Mitchell; Nicholas G Martin; Peter R Schofield; Sven Cichon; Markus M Nöthen; Hong Chang; Xiong-Jian Luo; Yiru Fang; Yong-Gang Yao; Chen Zhang; Marcella Rietschel; Ming Li
Journal:  Transl Psychiatry       Date:  2017-12-11       Impact factor: 6.222

2.  The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Julian Ramírez-Bello; Nonanzit Pérez-Hernández; Alma Delia Genis-Mendoza; Ana Fresan; Crystell Guadalupe Guzmán-Priego
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-28       Impact factor: 2.570

3.  Family-based association study of ZNF804A polymorphisms and autism in a Han Chinese population.

Authors:  Ziqi Wang; Tian Zhang; Jing Liu; Han Wang; Tianlan Lu; Meixiang Jia; Dai Zhang; Lifang Wang; Jun Li
Journal:  BMC Psychiatry       Date:  2019-05-23       Impact factor: 3.630

4.  ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders.

Authors:  Marco Calabrò; Laura Mandelli; Concetta Crisafulli; Marco Di Nicola; Roberto Colombo; Luigi Janiri; Soo-Jung Lee; Tae-Youn Jun; Sheng-Min Wang; Prakash S Masand; Ashwin A Patkar; Changsu Han; Chi-Un Pae; Alessandro Serretti
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

5.  Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.

Authors:  Liya Sun; Xuhan Yang; Jie Jiang; Xiaowen Hu; Ying Qing; Dandan Wang; Tianqi Yang; Chao Yang; Juan Zhang; Ping Yang; Peng Wang; Changqun Cai; Jijun Wang; Lin He; Chunling Wan
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

6.  Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations.

Authors:  Yongfeng Yang; Lu Wang; Lingyi Li; Wenqiang Li; Yan Zhang; Hong Chang; Xiao Xiao; Ming Li; Luxian Lv
Journal:  Transl Psychiatry       Date:  2018-08-07       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.